HMS Holdings Corp.

• The Biggest Losers of this Earnings Season: Are Any Priced to Buy?

  By Brian Nichols - December 4, 2012 | Tickers: ABMD, CTCT, HMSY, ACTV, WU

  I can’t imagine that being atop a list for the worst performing stocks of a quarter is a good thing for any company. It signals operational issues, lost confidence among shareholders, and a total lack of execution. However, looking back on history, most companies experience such a quarter at least once. With that being said I am looking at the top losers of Q3, and will determine if any more »

• 5 Stocks Hated by Hedge Funds Last Week

  By Meena Krishnamsetty - November 7, 2012 | Tickers: FLR, HMSY, PBI, RVBD, VRSN

  We have identified five stocks that had absolutely horrible days last week. Assuming the funds we track have not changed their holdings since the end of June, there were key funds that lost big money on these price drops. The first company on our list is HMS Holdings (NASDAQ: HMSY).

  The company was down over 23% on Friday, October 26th—around $6.30—after missing quarterly estimates and offering lower more »

• J.P. Morgan Healthcare Conference Schedule: Day One

  By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

  The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

  I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)